The percentages of Derlin-1 expression were 32.3% (10 of 31 cases), 47.8% (22/46), and 73.5% (72 of 98 cases) in normal bladder tissues, noninvasive BC tissues and invasive BC tissues, respectively. Here, DERL1 is linked to breast cancer.